CELLEVOLVE Trademark

Trademark Overview

On Monday, April 13, 2020, a trademark application was filed for CELLEVOLVE with the United States Patent and Trademark Office. The USPTO has given the CELLEVOLVE trademark a serial number of 88870139. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by CELLEVOLVE BIO, INC.. The CELLEVOLVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of cellular therapeutics
cellevolve

General Information

Serial Number88870139
Word MarkCELLEVOLVE
Filing DateMonday, April 13, 2020
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6412423
Registration DateTuesday, July 6, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Goods and ServicesResearch and development in the field of cellular therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 21, 2020
Primary Code042
First Use Anywhere DateMonday, June 1, 2020
First Use In Commerce DateMonday, June 1, 2020

Trademark Owner History

Party NameCELLEVOLVE BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameCELLEVOLVE BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameCELLEVOLVE BIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Trademark Events

Event DateEvent Description
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, June 3, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 2, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 5, 2021USE AMENDMENT FILED
Friday, May 28, 2021EXTENSION 1 GRANTED
Monday, March 29, 2021EXTENSION 1 FILED
Thursday, May 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 6, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, May 5, 2021EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, May 5, 2021PETITION TO REVIVE-GRANTED
Wednesday, May 5, 2021TEAS PETITION TO REVIVE RECEIVED
Wednesday, May 5, 2021TEAS STATEMENT OF USE RECEIVED
Monday, May 3, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 3, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 29, 2020ASSIGNED TO EXAMINER
Tuesday, April 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 16, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

cellevolve therapeutics cellular field development research